Tadashi Osaki Selected Research

Tadashi Osaki Research Topics

Disease

11	Neoplasms (Cancer) 08/2011 - 03/2002
8	Lung Neoplasms (Lung Cancer) 10/2008 - 02/2003
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2013 - 01/2007
3	Malignant Mesothelioma 08/2011 - 09/2006
3	Fibrosis (Cirrhosis) 03/2006 - 07/2002
2	Pneumonia (Pneumonitis) 03/2012 - 05/2009
2	Chronic Obstructive Pulmonary Disease (COPD) 09/2008 - 03/2006
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2006 - 02/2003
2	Erythema 09/2004 - 01/2004
1	Fever (Fevers) 03/2012
1	Inflammation (Inflammations) 03/2012
1	Atherosclerosis 01/2011
1	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 01/2007
1	Mesothelioma 09/2006
1	Asthma (Bronchial Asthma) 03/2006
1	Granuloma 08/2005
1	Leukopenia 09/2004
1	Leukemia 09/2004
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2004
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2004
1	Idiopathic Pulmonary Fibrosis 02/2004
1	Infections 02/2004
1	Breast Neoplasms (Breast Cancer) 01/2004
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2003
1	Autoimmune Diseases (Autoimmune Disease) 12/2003
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2003
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2002
1	Cachexia 07/2002
1	Colonic Neoplasms (Colon Cancer) 03/2002

Drug/Important Bio-Agent (IBA)

5	TetraspaninsIBA 05/2009 - 02/2003
4	Interleukin-18 (Interleukin 18)IBA 01/2011 - 03/2002
4	CytokinesIBA 01/2011 - 07/2002
3	AntigensIBA 04/2010 - 01/2004
3	WT1 ProteinsIBA 04/2010 - 01/2004
3	Tumor Biomarkers (Tumor Markers)IBA 10/2008 - 01/2004
3	Gefitinib (Iressa)FDA Link 03/2007 - 04/2006
3	ErbB Receptors (EGF Receptor)IBA 03/2007 - 04/2006
3	Proteins (Proteins, Gene)FDA Link 10/2006 - 08/2005
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2013 - 01/2010
2	Carboplatin (JM8)FDA LinkGeneric 01/2013 - 01/2010
2	InterleukinsIBA 01/2011 - 03/2002
2	Tyrosine Kinase InhibitorsIBA 01/2007 - 09/2006
2	IntegrinsIBA 10/2006 - 02/2003
2	Protein Subunit VaccinesIBA 04/2006 - 09/2004
2	Peptides (Polypeptides)IBA 09/2004 - 01/2004
2	VaccinesIBA 09/2004 - 01/2004
1	Gemcitabine FDA Link 01/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2012
1	Dietary Fats (Dietary Fat)IBA 01/2011
1	LipopolysaccharidesIBA 05/2009
1	Complementary DNA (cDNA)IBA 10/2008
1	flt3 ligand protein (flt3 ligand)IBA 10/2008
1	MesothelinIBA 10/2008
1	AsbestosIBA 10/2008
1	Peptide Hydrolases (Proteases)FDA Link 09/2008
1	Phosphotransferases (Kinase)IBA 03/2007
1	Small Interfering RNA (siRNA)IBA 10/2006
1	Pharmaceutical PreparationsIBA 10/2006
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2006
1	Extracellular Matrix ProteinsIBA 10/2006
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2006
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 10/2006
1	ErbB-2 ReceptorIBA 09/2006
1	titanium silicide (TS-1)IBA 08/2006
1	Oxycodone (Oxycontin)FDA LinkGeneric 08/2006
1	Cancer VaccinesIBA 04/2006
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2006
1	Theophylline (Theon)FDA LinkGeneric 03/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2005
1	Surface-Active Agents (Surfactants)IBA 02/2004
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2004
1	ImmunosorbentsIBA 02/2004
1	E-SelectinIBA 02/2004
1	SelectinsIBA 02/2004
1	Biological ProductsIBA 02/2004
1	EnzymesIBA 02/2004
1	Apoprotein(a) (Apolipoprotein (a))IBA 02/2004
1	C-Reactive ProteinIBA 02/2004
1	Monatide (IMS 3015)IBA 01/2004
1	Sialyl Lewis X AntigenIBA 01/2004
1	HLA-A Antigens (HLA-A)IBA 01/2004
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2004
1	Interleukin-6 (Interleukin 6)IBA 05/2003
1	Integrin beta1IBA 02/2003
1	Bleomycin (Blenoxane)FDA LinkGeneric 07/2002
1	p38 Mitogen-Activated Protein KinasesIBA 07/2002
1	indium-bleomycinIBA 07/2002
1	Cytostatic AgentsIBA 03/2002

Therapy/Procedure

4	Therapeutics 01/2013 - 04/2006
3	Immunotherapy 04/2010 - 01/2004
1	Maintenance Chemotherapy 01/2013
1	General Anesthesia 03/2012
1	Combination Drug Therapy (Combination Chemotherapy) 01/2010
1	Intravenous Injections 08/2005
1	Intraperitoneal Injections 03/2002